Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Predictive Oncology Inc. POAI

Predictive Oncology Inc.’s (NASDAQ: POAI) Unique Assets, AI Capability Address Unmet Need in Growing Field of Precision Medicine

Posted on November 7, 2019 by MissionIR

Predictive Oncology is at forefront of growing trend of precision medicine The company applies smart tumor profiling, AI platform to extensive genomic and biomarker patient data sets POAI has large amounts of historical, standardized patient data from clinical testing that … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Achieves First Milestone in Cancer Quest 2020 Project

Posted on October 31, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, this morning announced that its Helomics subsidiary has begun to sequence tumor cases from its collaboration with the UPMC Magee Women’s Hospital (http://ibn.fm/b9BBo). According … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc.’s (NASDAQ: POAI) Valuable Database Offers Hope to Cancer Patients of Today and Tomorrow

Posted on October 30, 2019 by MissionIR

Predictive Oncology Inc. harnessing the power of artificial intelligence and its rich database of tumor data to help clinicians match cancer patients with most effective drug treatments Like Amazon’s customer dataset, POAI’s deep database of historical tumor information positions it … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Achieves Financial Milestone via Largest Single-Hospital STREAMWAY(R) System Sale

Posted on October 28, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI), a company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently announced that its Skyline Medical Division completed the sale of 10 STREAMWAY(R) Systems to a major New York hospital (http://ibn.fm/dXHwp). An … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Helomics Division to Present Initial Findings of UK 100,000 Genomes Project Data at Inaugural Conference

Posted on October 24, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI), a company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that Helomics CTO Dr. Mark Collins will speak during the scientific session of the inaugural UK 100,000 Genomes Project (“UK100K … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Utilizing Artificial Intelligence, Smart Tumor Profiling to Augment Clinical Outcomes

Posted on October 18, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI), a developer of highly adaptable assessment methods for cancer patients to help guide personalized treatments, employs its proprietary smart tumor profiling and artificial intelligence (“AI”) platform to predict tumor drug response and improve clinical outcomes for … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Takes Part in Groundbreaking Genomes Project

Posted on October 11, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI) is a developer of highly adaptable assessment methods for cancer patients to help guide personalized treatments. An article discussing the company reads, “As part of Predictive Oncology’s commitment to determining the best pathways for more individualized … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Continues to Innovate to Improve Outcomes for Cancer Patients

Posted on October 8, 2019 by MissionIR

POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response TumorGenesis is developing innovative techniques for growing tumors in laboratory settings Helomics uses vital information from patients’ own living tumors to assist oncologists in … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices Public Offering; Subsidiary Sells 10 STREAMWAY Systems to Leading Teaching Hospital in New York

Posted on October 2, 2019 by MissionIR

Predictive Oncology (NASDAQ: POAI) today announced pricing for the public offering of its common stock that the company announced in a news release on Tuesday. The company is offering 6,335,537 shares on a “best efforts” basis at a price of … Continue reading →

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Participates in UK 100,000 Genomes Project

Posted on October 1, 2019 by MissionIR

The main subsidiary of POAI partnered with Genomics England for the groundbreaking UK 100,000 Genomes Project POAI is positioned on the cutting edge of future cancer treatments The company’s AI-driven platforms are improving cancer patient outcomes and setting a new … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment